Laden...
Dear Subscriber, I am pleased to invite you to the fourth annual FierceBiotech Executive Summit: London taking place on Tuesday, October 30th at the Royal Society of Medicine in London. This exciting half-day event will feature engaging panel discussions, a fireside chat, a cocktail reception, and plenty of opportunities to network with your peers. Register now to join leading experts as we discuss a post-Brexit world and what this means for U.K. biomedical science. We'll also look at the burgeoning new digital health industry and how new innovations can help research. Here’s the lineup: Panel: Challenges and Opportunities for Life Science Post-Brexit Dr. Chris Doherty, Managing Director, Alderley Park Matthew Durdy (High Honors), MA (Oxon.), FCSI, Chief Business Officer, Cell and Gene Therapy Catapult Dr. Peter Jackson, Executive Director, The AMR Centre Moderator: Ben Adams, Editor, FierceBiotechFireside Chat: Biotech's View of Brexit Steve Bates, CEO, BioIndustry Association Moderator: Ben Adams, Editor, FierceBiotechPanel: Tapping Britain's Digital Healthcare Industry Dr. Munna Choudhury, Independent Consultant, Affiliated with Accenture and Alacramed Moderator: Carly Helfand, Senior Editor, FiercePharmaSeats are limited so don’t wait – click here to register. Best Regards, Rebecca Willumson - If you have questions about this event, please email [email protected]. |
| This blast was sent on behalf of FierceBiotech a division of FierceMarkets. |
Laden...
Laden...
